Our Managing Director and Founder, Dr Leonid Shapiro, has been recognised as the Sector Specialist at the HealthInvestor Power 50 Awards 2017.
Candesic is a leading strategy consultancy
head-quartered in London, serving private operators, investors, and public sector organisations.
Candesic Senior Partner and Cambridge Angels Investor Dr Michelle Tempest, featured in a report brought by Barclays Eagle Labs
Candesic Senior Partner and Cambridge Angels Investor Dr Michelle Tempest, featured in a report reviewing the UK's AI corporate ecosystem. The report was brought by Barclays Eagle Labs, UK Government and Beauhurst. The global landscape of artificial intelligence is rapidly evolving, and the UK is a leader as it integrates AI across different sectors and brings together all stakeholders at events such as the Government AI Safety Summit 2023. Other AI experts included: -> Rafie Faruq (Co-founder and CEO of GENIE AI) -> Steve King (CEO of Dragonfly AI) -> Rachel Curtis (Co-founder and CEO of Inicio AI) -> Simon…
Candesic advisor Professor Stephen Smith as a speaker at The Women's Health Technology event
Candesic advisor Professor Stephen Smith spoke at a The Women`s Health Technology GIANT Health Event in London. His participation in the panel on "How do various sectors in Women's Health overcome barriers to meaningful progress?" was moderated by Professor Dame Lesley Regan and delved into the key reasons the gender gap exists in healthcare. Professor Stephen Smith has a wealth of experience in the area among other things as a Former Professor of Obstetrics and Gynaecology at Cambridge University. Click on the link to find out more about the event.
Dr Michelle Tempest featured in the new Financial Times
Dr Michelle Tempest, Senior Partner at Candesic, featured in the Financial Times discussing the implications of increased reliance of the NHS on private providers. Private sector outsourcing has become a critical element for the NHS to deliver patient care, and while it is currently resulting in improved outcomes for patients, to address the underlying structural issues will require continued public and private investment. Click on the link to subscribe and read more.
© Candesic 2023